- Investing Ideas
- /
- Australian Healthcare Top Stock Picks from Analysts
Australian Healthcare Top Stock Picks from Analysts
Results
17
Companies which are more than 50% undervalued based on analyst price target.
17 companies
EBR Systems
Market Cap: AU$528.5m
Develops implantable systems for wireless tissue stimulation.
EBR
AU$1.18
7D
-8.9%
1Y
42.4%
Paragon Care
Market Cap: AU$504.9m
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.
PGC
AU$0.30
7D
0%
1Y
-27.4%
Anteris Technologies Global
Market Cap: AU$236.9m
A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
AVR
AU$6.57
7D
-19.5%
1Y
-45.3%
EMVision Medical Devices
Market Cap: AU$162.5m
Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
EMV
AU$1.90
7D
-12.0%
1Y
-4.3%
Cyclopharm
Market Cap: AU$95.6m
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.
CYC
AU$0.86
7D
-2.3%
1Y
-38.6%
Mach7 Technologies
Market Cap: AU$71.7m
Develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally.
M7T
AU$0.30
7D
5.2%
1Y
-44.5%
ImpediMed
Market Cap: AU$71.3m
A medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally.
IPD
AU$0.035
7D
0%
1Y
-39.7%
BlinkLab
Market Cap: AU$66.4m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$0.53
7D
-3.6%
1Y
120.8%
Beamtree Holdings
Market Cap: AU$56.7m
Provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally.
BMT
AU$0.20
7D
-11.4%
1Y
-38.1%
Compumedics
Market Cap: AU$56.7m
Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.
CMP
AU$0.29
7D
7.3%
1Y
1.7%
Micro-X
Market Cap: AU$53.4m
Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.
MX1
AU$0.08
7D
-9.6%
1Y
14.3%
CleanSpace Holdings
Market Cap: AU$53.2m
Designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally.
CSX
AU$0.68
7D
-10.5%
1Y
30.8%
Microba Life Sciences
Market Cap: AU$49.9m
Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.
MAP
AU$0.082
7D
-3.5%
1Y
-51.8%
Vitasora Health
Market Cap: AU$46.4m
An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.
VHL
AU$0.027
7D
-3.6%
1Y
-27.0%
INOVIQ
Market Cap: AU$44.7m
Develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.
IIQ
AU$0.40
7D
0%
1Y
-15.8%
Nova Eye Medical
Market Cap: AU$44.1m
Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.
EYE
AU$0.15
7D
3.3%
1Y
-11.4%
MedAdvisor
Market Cap: AU$26.3m
Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.
MDR
AU$0.042
7D
0%
1Y
-89.2%